Capital Analysts LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Buy |
3,088
+525
| +20% | +$187K | 0.03% | 326 |
|
|
2025
Q4 | $839K | Sell |
2,563
-3
| -0.1% | -$952 | 0.02% | 338 |
|
|
2025
Q3 | $724K | Buy |
2,566
+91
| +4% | +$26.4K | 0.02% | 362 |
|
|
2025
Q2 | $691K | Buy |
2,475
+4
| +0.2% | +$1.13K | 0.02% | 334 |
|
|
2025
Q1 | $769K | Buy |
2,471
+610
| +33% | +$180K | 0.03% | 300 |
|
|
2024
Q4 | $485K | Sell |
1,861
-29
| -2% | -$8.6K | 0.02% | 336 |
|
|
2024
Q3 | $608K | Buy |
1,890
+33
| +2% | +$10.8K | 0.02% | 299 |
|
|
2024
Q2 | $580K | Buy |
1,857
+141
| +8% | +$41.4K | 0.03% | 310 |
|
|
2024
Q1 | $488K | Buy |
1,716
+14
| +0.8% | +$4.1K | 0.02% | 318 |
|
|
2023
Q4 | $490K | Sell |
1,702
-16
| -0.9% | -$4.36K | 0.02% | 316 |
|
|
2023
Q3 | $462K | Buy |
1,718
+121
| +8% | +$30.2K | 0.03% | 308 |
|
|
2023
Q2 | $355K | Buy |
1,597
+9
| +0.6% | +$2.09K | 0.02% | 328 |
|
|
2023
Q1 | $383K | Buy |
1,588
+106
| +7% | +$26K | 0.02% | 317 |
|
|
2022
Q4 | $389K | Sell |
1,482
-111
| -7% | -$29.8K | 0.02% | 322 |
|
|
2022
Q3 | $360K | Buy |
1,593
+21
| +1% | +$5.09K | 0.02% | 297 |
|
|
2022
Q2 | $382K | Buy |
1,572
+4
| +0.3% | +$980 | 0.03% | 282 |
|
|
2022
Q1 | $379K | Sell |
1,568
-46
| -3% | -$10.6K | 0.02% | 291 |
|
|
2021
Q4 | $363K | Sell |
1,614
-98
| -6% | -$20.7K | 0.02% | 294 |
|
|
2021
Q3 | $364K | Buy |
1,712
+146
| +9% | +$33.6K | 0.02% | 286 |
|
|
2021
Q2 | $381K | Sell |
1,566
-7,910
| -83% | -$1.95M | 0.03% | 276 |
|
|
2021
Q1 | $2.36M | Buy |
9,476
+1,661
| +21% | +$396K | 0.16% | 120 |
|
|
2020
Q4 | $1.8M | Buy |
7,815
+434
| +6% | +$100K | 0.16% | 110 |
|
|
2020
Q3 | $1.88M | Buy |
7,381
+389
| +6% | +$96.4K | 0.18% | 103 |
|
|
2020
Q2 | $1.65M | Sell |
6,992
-234
| -3% | -$53.4K | 0.17% | 105 |
|
|
2020
Q1 | $1.47M | Sell |
7,226
-305
| -4% | -$66.6K | 0.18% | 102 |
|
|
2019
Q4 | $1.82M | Buy |
7,531
+224
| +3% | +$49.4K | 0.18% | 106 |
|
|
2019
Q3 | $1.41M | Buy |
7,307
+126
| +2% | +$24.2K | 0.15% | 129 |
|
|
2019
Q2 | $1.32M | Sell |
7,181
-440
| -6% | -$78.8K | 0.14% | 134 |
|
|
2019
Q1 | $1.45M | Sell |
7,621
-263
| -3% | -$50.2K | 0.17% | 110 |
|
|
2018
Q4 | $1.53M | Sell |
7,884
-38
| -0.5% | -$7.41K | 0.2% | 88 |
|
|
2018
Q3 | $1.64M | Buy |
7,922
+131
| +2% | +$25.8K | 0.19% | 96 |
|
|
2018
Q2 | $1.44M | Buy |
7,791
+145
| +2% | +$25.6K | 0.17% | 98 |
|
|
2018
Q1 | $1.3M | Buy |
7,646
+666
| +10% | +$122K | 0.16% | 98 |
|
|
2017
Q4 | $1.21M | Buy |
6,980
+310
| +5% | +$54.9K | 0.15% | 111 |
|
|
2017
Q3 | $1.24M | Buy |
6,670
+404
| +6% | +$71.6K | 0.17% | 99 |
|
|
2017
Q2 | $1.08M | Buy |
+6,266
| New | +$1.02M | 0.15% | 108 |
|
|
2016
Q3 | – | Sell |
-6,513
| Closed | -$991K | – | 390 |
|
|
2016
Q2 | $991K | Buy |
6,513
+30
| +0.5% | +$4.66K | 0.2% | 89 |
|
|
2016
Q1 | $972K | Buy |
6,483
+441
| +7% | +$65.5K | 0.2% | 94 |
|
|
2015
Q4 | $981K | Sell |
6,042
-2,564
| -30% | -$403K | 0.2% | 97 |
|
|
2015
Q3 | $1.19M | Buy |
8,606
+4,451
| +107% | +$702K | 0.23% | 97 |
|
|
2015
Q2 | $638K | Buy |
4,155
+353
| +9% | +$56.5K | 0.13% | 123 |
|
|
2015
Q1 | $608K | Buy |
3,802
+1,191
| +46% | +$188K | 0.13% | 111 |
|
|
2014
Q4 | $416K | Sell |
2,611
-159
| -6% | -$24.8K | 0.09% | 123 |
|
|
2014
Q3 | $389K | Buy |
2,770
+338
| +14% | +$44.1K | 0.09% | 114 |
|
|
2014
Q2 | $288K | Buy |
2,432
+722
| +42% | +$83.6K | 0.07% | 136 |
|
|
2014
Q1 | $211K | Buy |
1,710
+249
| +17% | +$30.2K | 0.06% | 135 |
|
|
2013
Q4 | $167K | Buy |
1,461
+183
| +14% | +$20.8K | 0.05% | 152 |
|
|
2013
Q3 | $143K | Buy |
1,278
+6
| +0.5% | +$651 | 0.04% | 147 |
|
|
2013
Q2 | $126K | Buy |
+1,272
| New | +$132K | 0.04% | 152 |
|
Other funds holding AMGN
VCM
VPM
Capital Analysts LLC's AMGN Position: Q1 2026 in Review
Capital Analysts LLC increased its Amgen (AMGN) stake by 20% in Q1 2026, buying an estimated $187K and bringing the position to 3,088 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #326.
Capital Analysts LLC first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.36M in Q1 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capital Analysts LLC held 3,088 shares of Amgen worth $1.09M as of Q1 2026.
- Capital Analysts LLC bought 525 Amgen shares in Q1 2026, an estimated $187K.
- Amgen made up 0.03% of Capital Analysts LLC's portfolio in Q1 2026, its #326 holding.
- Capital Analysts LLC first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
- Capital Analysts LLC's Amgen position peaked at $2.36M in Q1 2021.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.